-
Healthcare Utilization and Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Ontario, Canada: An Observational Study
Mar 10, 2025, 14:00 PM -
Association of Systemic Lupus Erythematosus and Psychosocial Outcomes: Analysis of a Nationally Representative Data, 2017-2022
Mar 10, 2025, 14:00 PM -
Determinants of Clinical Trial Participation in Prostate Cancer Patients: A Nationwide Medicare Analysis
Mar 10, 2025, 14:00 PM -
Real-World Characteristics and Treatment Patterns With Nintedanib in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective US Claims Study
Mar 10, 2025, 14:00 PM -
Comparison of Rare Disease Patient and Caregiver Disease Burden in Terms of Economic, Social, and Interpersonal Impact and Impact on Quality Of Life: Results From an International Survey
Mar 10, 2025, 14:00 PM -
The Potential Impact of COVID-19 Vaccine Efficacy and Vaccination Coverage on Health Equity Among United States (US) Older Adults
Mar 10, 2025, 14:00 PM -
Time Toxicity of Bispecific Antibody (BsAb) Options in Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Fixed-Duration Mosunetuzumab Versus Treat to Progression Epcoritamab
Mar 10, 2025, 14:00 PM -
Economic Burden of Rheumatoid Arthritis in Low- and Middle-Income Countries: Systematic Review
Mar 10, 2025, 14:00 PM -
The Prevalence Of Multi-Comorbid Patients In The US: The Potential For Benefit Being Greater Than Bargained For And The Need For Multi-Indication Value Assessment
Mar 10, 2025, 14:00 PM -
Integrating Dynamic Pricing Into Cost-Effectiveness Models: Implications for US-Based Drug Evaluations
Mar 10, 2025, 14:00 PM -
Real-World BReast CAncer gene 1 (BRCA1) and BReast CAncer gene 2 (BRCA2) Testing Trends by Race for Patients with Metastatic Prostate Cancer (mPC) from 2015 to 2024 in the Community Oncology Setting in the United States (US)
Mar 10, 2025, 14:00 PM -
Unlocking AI's Potential in Pricing and Reimbursement: Insights Across Global Healthcare Archetypes
Mar 10, 2025, 14:00 PM -
Does Health Plan Enrollment Data Support Long-term Follow-up of Patients with Chronic Disease? Assessment of the Healthcare Integrated Research Database (HIRD®)
Mar 10, 2025, 14:00 PM -
Economic and Environmental Impact of Decentralized Cancer Care (DCC) in Oncology: An Innovative Experience in the French Alps
Mar 10, 2025, 14:00 PM -
Health-Related Quality of Life in Individuals with Diagnosed Depression, Self-Reported Depression, and Non-Depressed: A Multi-Center Cross-Sectional Study
Mar 10, 2025, 14:00 PM -
Expected vs. Observed Mortality Rates, Expressed As Number Needed to Treat, From a Phase 3 Clinical Trial Program of Patients With Hyperphagia and Prader-Willi Syndrome Treated With Diazoxide Choline Extended Release (DCCR)
Mar 10, 2025, 14:00 PM -
Real-World Patient Characteristics and Treatment Patterns in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients With Long-Term Survivorship
Mar 10, 2025, 14:00 PM -
Impact of Valbenazine on Improvements in Disability and Functional Impairment in Patients With Tardive Dyskinesia (TD): Sheehan Disability Scale (SDS) Results From a Phase 4 Randomized Withdrawal Study (NCT03891862)
Mar 10, 2025, 14:00 PM -
Impact of Single-Patient use Electrocardiogram Monitoring in the Cost of Care and Infection Prevention of CABG Surgery Patients in the USA
Mar 10, 2025, 14:00 PM -
Costs Avoided by the Inclusion of Finerenone Based on Hospitalization and Death Due to Cardiovascular Events and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia
Mar 10, 2025, 14:00 PM
